Search Results 1271-1280 of 27530 for female

  1. A Study to Evaluate Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients with Chronic Myeloid Leukemia and Persistently- Detectable Minimal Residual Disease - Mayo Clinic

    A female of childbearing potential is any woman, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following ...

  2. Publications - Sherif A. El Nashar, M.B., B.Ch., M.S. - Mayo Clinic

    Tamsulosin vs placebo to prevent postoperative urinary retention following female pelvic reconstructive surgery: a multicenter randomized controlled trial.

  3. A Study to Compare Cabozantinib versus Sunitinib to Treat Metastatic Variant Histology Renal Cell Carcinoma Patients - Mayo Clinic

    Female subjects of childbearing potential must not be pregnant at screening. Females of childbearing potential are defined as premenopausal females capable ...

  4. Early Fluconazole Treatment For Coccidiodomycosis Pneumonia - Mayo Clinic

    **Female subjects must avoid becoming pregnant by using one of the following acceptable methods of birth control for 30 days prior to study drug dosing: and ...

  5. A Phase 3 Study Comparing Oral Ixazomib Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

    Female patients who: Are postmenopausal for at least 24 months before the screening visit, OR; Are surgically sterile, OR; Females of childbearing potential ...

  6. Dizziness in adults - Mayo Clinic

    Chest pain; Difficulty breathing; Numbness or weakness; Fainting; Blurred or double vision; Rapid or irregular heartbeat; Confusion or trouble talking; Nausea ...

  7. Spina bifida - Symptoms and causes - Mayo Clinic

    Also, female babies are affected more often than male babies. Although healthcare professionals and researchers don't know why spina bifida occurs, they have ...

  8. Observational, Non-Interventional Study Supporting Validation of VO2Max Estimation Methods Using Results in Patients Receiving Standard of Care Cardiopulmonary Exercise Tests (CPET) - Mayo Clinic

    ... female participants aged 18 to 80 and (Standard of Care) 100 participants. Participation eligibility. Participant eligibility includes age, gender, type and ...

  9. A Study to Evaluate Whether or Not Extracellular Counts and Content Can Diagnose Alcoholic Hepatitis - Mayo Clinic

    Age >21 year old; both male or female. MELD score 10 or higher. Patients ... Pregnant females or other at-risk population. Participating Mayo Clinic ...

  10. A Study to Assess the Effectiveness and Safety of Ublituximab in combination with Umbralisib and Venetoclax (U2-V) Compared to Ublituximab and Umbralisib (U2) in Subjects with Chronic Lymphocytic Leukemia (CLL) - Mayo Clinic

    Male or female ≥ 18 years of age. Ability to swallow and retain oral medication. Female subjects who are not of child-bearing potential, and female ...